Leva, Giacomo
Leva, Giacomo
Dipartimento di Scienze Biomolecolari (DISB)
Expression of circulating KRAS-4a and KRAS-4b mRNA isoforms in Patients with metastatic lung adenocarcinoma treated with Pembrolizumab or chemotherapy plus Pembrolizumab by liquid biopsy. Clinical impact and assoociation with circulating Pd-L1
2023 Palladino, S.; Ruzzo, A.; Emili, R.; De Lisa, M.; Catalano, V.; Leva, G.; Sarti, D.; Magnani, M.; Graziano, F.; Chiari, R.
KRAS-mutated patients with liver-only metastatic colorectal cancer treated with Bevacizumab and chemotherapy. Functional analysis of TP53 mutations and outcomes
2024 Ruzzo, A.; Fischer, N.; Palladino, S.; Chiari, R.; Catalano, V.; Giordani, P.; Malkin, D.; Leva, G.; Tamburrano, T.; Patriti, A.; Petrelli, F.; Sarti, D.; Graziano, F.
Multicenter prospective study of programmed death 1 (PD-1) single-nucleotide polymorphisms (SNPs) in patients with metastatic lung adenocarcinoma (MLA) treated with pembrolizumab (P)
2025 Chiari, R.; Ruzzo, A.; Leva, G.; Russano, M.; Fiorenti, M.; Catalano, V.; Sarti, D.; Emili, R.; Bisonni, R.; Rinaldi, S.; Graziano, F.
Prospective study of programmed death 1 (PD-1) single-nucleotide polymorphisms in patients with metastatic lung adenocarcinoma treated with Pembrolizumab
2025 Rita, Chiari; Ruzzo, Annamaria; Leva, Giacomo; Marco, Russano; Matteo, Fiorenti; Vincenzo, Catalano; Donatella, Sarti; Rita, Emili; Renato, Bisonni; Rinaldi, Silvia; Graziano, Francesco